Quick Answer
GENTEX CORP reported Cash and Equivalents of $145.65 million for fiscal year 2025.
GENTEX CORP Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $145.65M | -37.6% |
| 2024 | $233.32M | +3.0% |
| 2023 | $226.44M | +5.4% |
| 2022 | $214.75M | -18.1% |
| 2021 | $262.31M | -38.0% |
| 2020 | $423.37M | +42.9% |
| 2019 | $296.32M | +36.5% |
| 2018 | $217.03M | -61.9% |
| 2017 | $569.73M | +4.3% |
| 2016 | $546.48M | -0.9% |
| 2015 | $551.56M | +10.9% |
| 2014 | $497.43M | +60.7% |
| 2013 | $309.59M | -20.6% |
| 2012 | $389.68M | +8.9% |
| 2011 | $357.99M | +2.8% |
| 2010 | $348.35M | +3.6% |
| 2009 | $336.11M | +14.2% |
| 2008 | $294.31M | -7.4% |
| 2007 | $317.72M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $178.59M | -0.6% | +49.1% |
| June 30, 2025 | $119.77M | -54.0% | -58.2% |
| March 31, 2025 | $286.56M | +15.1% | +22.8% |
| December 31, 2024 | $233.32M | +3.0% | +29.9% |
| September 30, 2024 | $179.64M | -31.1% | -31.0% |
| June 30, 2024 | $260.24M | +9.5% | +4.5% |
| March 31, 2024 | $249.00M | +15.6% | +10.0% |
| December 31, 2023 | $226.44M | +5.4% | -13.1% |
- GENTEX CORP showed a decrease of -37.6% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2007–2025 period, GENTEX CORP’s cash and equivalents has declined by 54.2% (from $317.72 million to $145.65 million).
- The most recent figure is from GENTEX CORP’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: